View in EDS HTML Full Text PDF Full Text

Siglec15/TGF-β bispecific antibody mediates synergistic anti-tumor response against 4T1 triple negative breast cancer in mice.

Saved in:
Bibliographic Details
Title: Siglec15/TGF-β bispecific antibody mediates synergistic anti-tumor response against 4T1 triple negative breast cancer in mice.
Authors: Shen L; Division of Pharmacoengineering and Molecular Pharmaceutics Eshelman School of Pharmacy, University of North Carolina Chapel Hill North Carolina USA., Schaefer AM; Department of Biomedical Engineering University of North Carolina Chapel Hill North Carolina USA., Tiruthani K; Division of Pharmacoengineering and Molecular Pharmaceutics Eshelman School of Pharmacy, University of North Carolina Chapel Hill North Carolina USA., Wolf W; Division of Pharmacoengineering and Molecular Pharmaceutics Eshelman School of Pharmacy, University of North Carolina Chapel Hill North Carolina USA., Lai SK; Division of Pharmacoengineering and Molecular Pharmaceutics Eshelman School of Pharmacy, University of North Carolina Chapel Hill North Carolina USA.; Department of Biomedical Engineering University of North Carolina Chapel Hill North Carolina USA.; Department of Immunology and Microbiology University of North Carolina Chapel Hill North Carolina USA.
Source: Bioengineering & translational medicine [Bioeng Transl Med] 2024 Mar 11; Vol. 9 (5), pp. e10651. Date of Electronic Publication: 2024 Mar 11 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: John Wiley & Sons Inc Country of Publication: United States NLM ID: 101689146 Publication Model: eCollection Cited Medium: Print ISSN: 2380-6761 (Print) Linking ISSN: 23806761 NLM ISO Abbreviation: Bioeng Transl Med Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39553435
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Siglec15/TGF-β bispecific antibody mediates synergistic anti-tumor response against 4T1 triple negative breast cancer in mice.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Shen+L%22">Shen L</searchLink>; Division of Pharmacoengineering and Molecular Pharmaceutics Eshelman School of Pharmacy, University of North Carolina Chapel Hill North Carolina USA.<br /><searchLink fieldCode="AU" term="%22Schaefer+AM%22">Schaefer AM</searchLink>; Department of Biomedical Engineering University of North Carolina Chapel Hill North Carolina USA.<br /><searchLink fieldCode="AU" term="%22Tiruthani+K%22">Tiruthani K</searchLink>; Division of Pharmacoengineering and Molecular Pharmaceutics Eshelman School of Pharmacy, University of North Carolina Chapel Hill North Carolina USA.<br /><searchLink fieldCode="AU" term="%22Wolf+W%22">Wolf W</searchLink>; Division of Pharmacoengineering and Molecular Pharmaceutics Eshelman School of Pharmacy, University of North Carolina Chapel Hill North Carolina USA.<br /><searchLink fieldCode="AU" term="%22Lai+SK%22">Lai SK</searchLink>; Division of Pharmacoengineering and Molecular Pharmaceutics Eshelman School of Pharmacy, University of North Carolina Chapel Hill North Carolina USA.; Department of Biomedical Engineering University of North Carolina Chapel Hill North Carolina USA.; Department of Immunology and Microbiology University of North Carolina Chapel Hill North Carolina USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101689146%22">Bioengineering & translational medicine</searchLink> [Bioeng Transl Med] 2024 Mar 11; Vol. 9 (5), pp. e10651. <i>Date of Electronic Publication: </i>2024 Mar 11 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons+Inc%22">John Wiley & Sons Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101689146 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2380-6761 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223806761%22">23806761 </searchLink><i>NLM ISO Abbreviation: </i>Bioeng Transl Med <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39553435
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/btm2.10651
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e10651
    Titles:
      – TitleFull: Siglec15/TGF-β bispecific antibody mediates synergistic anti-tumor response against 4T1 triple negative breast cancer in mice.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Shen L
      – PersonEntity:
          Name:
            NameFull: Schaefer AM
      – PersonEntity:
          Name:
            NameFull: Tiruthani K
      – PersonEntity:
          Name:
            NameFull: Wolf W
      – PersonEntity:
          Name:
            NameFull: Lai SK
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 11
              M: 03
              Text: 2024 Mar 11
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 2380-6761
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Bioengineering & translational medicine
              Type: main
ResultId 1